Drug Profile
(+)-Dihydrocalanolide A
Alternative Names: DHCal A; NSC 678323Latest Information Update: 04 Sep 2002
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV-1 infections
Most Recent Events
- 21 Oct 1999 Preclinical development for HIV-1 infections in USA (PO)
- 16 Aug 1999 A preclinical study has been added to the pharmacokinetics section
- 05 Aug 1999 New profile